Peter Cole, MD
Albany Medical College · University of Minnesota · Rutgers, The State University of New Jersey
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Cole, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02901613 · Prophylactic Post-Cesarean Incisional Negative-pressure Wound Therapy in Morbidly Obese PatientsAlbany Medical College · unknown · Negative-pressure Wound Therapy, Morbid Obesity, Cesarean Section · principal investigator
- N/ANCT00849771 · Operative Versus Nonoperative Treatment for Scapula FracturesVanderbilt University · withdrawn · Scapula Fracture, Clavicle Fracture · principal investigator
- N/ANCT00176553 · A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate NeurotoxicityUniversity of Medicine and Dentistry of New Jersey · terminated · Neurotoxicity Syndromes · principal investigator
- Ph2NCT00070304 · Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's LymphomaChildren's Oncology Group · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.